Bailard’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,300
Closed -$210K 748
2021
Q2
$210K Sell
1,300
-1,200
-48% -$194K 0.01% 665
2021
Q1
$201K Sell
2,500
-59,800
-96% -$4.81M 0.01% 667
2020
Q4
$3.39M Buy
62,300
+2,200
+4% +$120K 0.15% 118
2020
Q3
$1.2M Hold
60,100
0.06% 183
2020
Q2
$1.26M Buy
+60,100
New +$1.26M 0.07% 179